Chris Clendening Takes the Helm at Precision for Medicine's Specialty Labs

Chris Clendening Takes Charge at Precision for Medicine's Specialty Labs

Bethesda, MD - July 14, 2026 - Precision for Medicine, renowned for its biomarker-driven clinical research and development, has welcomed industry luminary Chris Clendening as the new General Manager of Labs Translational Sciences. In this pivotal role, Clendening will lead the company’s global specialty labs sector, directing operational delivery, strategic growth, and the incorporation of AI-enhanced methodologies to expedite biomarker research.

A Proven Leader Joins the Ranks

Clendening arrives at Precision with a wealth of experience in laboratory strategy and operations, primarily honed through transformative roles in complex clinical trial environments. Most recently, he held the position of Senior Vice President of Biotechnology Operations and Product Development at Clario, where he played a significant role in elevating lab operations. Before that, his tenure at PPD Central Labs marked him as a key figure in creating an innovative central laboratory platform, earning him the prestigious Center Watch Award for Innovation.

“It is a significant endorsement of Precision's stance in the market that a leader of Chris's caliber is joining us,” expressed Sofia Baig, President of Precision for Medicine. “Our mission revolves around partnering with innovators ready to challenge conventional norms, and Chris exemplifies this ethos. He carries with him a vast experience that aligns with our aspirations in an industry swiftly being reshaped by AI and enhanced biomarker utilization.”

Accelerating Clinical Development

Clendening is particularly drawn to the open and collaborative culture at Precision, as well as the leadership's commitment to growth and innovation. He notes, “The rapid evolution of our industry and the immense potential AI holds to transform laboratory and clinical trial operations is inspiring. Precision finds itself in a unique position to offer the next generation of specialty lab services. Unlike legacy companies, we possess the agility to pivot quickly and develop smarter, more efficient solutions.”

With his new responsibilities, Clendening aims to leverage this operational agility to create integrated and advanced scientific solutions for Precision's clients across the globe. His approach is anchored in practical execution and a collaborative spirit, cultivated over years of leadership spurred by a strong educational foundation in biology and chemistry from Muskingum University.

A Legacy of Hands-On Leadership

Residing in Cincinnati, Ohio, with his family, Clendening credits his disciplined leadership style to his upbringing on a family dairy farm, instilling in him the importance of accountability and consistency. These principles are essential as he steps into his role at Precision, focusing on delivering world-class laboratory services that meet the evolving needs of the life sciences sector.

About Precision for Medicine: Precision for Medicine stands as the first clinical research and development services organization aspiring to transform how life science companies leverage biomarkers for patient treatment. With a vision of melding trial design with deep scientific insights and advanced data intelligence, Precision accelerates clinical development and approval processes. As part of the Precision Medicine Group, which spans over 50 locations globally, Precision for Medicine employs more than 3,500 experts dedicated to pioneering advancements in healthcare.